1 documents found
Information × Registration Number 0125U002133, R & D request Title A randomised, double-blind, placebo-controlled, international, multicentre, Phase 3 study to evaluate the efficacy and safety of Ticagrelor and acetylsalicylic acid (ASA) in preventing stroke and death in patients with acute ischaemic stroke or transient ischaemic attack THALES- Acute stroke or transient ischaemic attack in patients treated with Ticagrelor and acetylsalicylic acid (ASA) to prevent stroke and death Head Lytvynenko Nataliia V., Доктор медичних наук Registration Date 11-04-2025 Organization Poltava State Medical University popup.description1 Evaluation of the efficacy and safety of Ticagrelor and acetylsalicylic acid (ASA) for the prevention of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack popup.nrat_date 2025-04-11 Close
search.res_rk
A randomised, double-blind, placebo-controlled, international, multicentre, Phase 3 study to evaluate the efficacy and safety of Ticagrelor and acetylsalicylic acid (ASA) in preventing stroke and death in patients with acute ischaemic stroke or transient ischaemic attack THALES- Acute stroke or transient ischaemic attack in patients treated with Ticagrelor and acetylsalicylic acid (ASA) to prevent stroke and death
Head: Lytvynenko Nataliia V.. A randomised, double-blind, placebo-controlled, international, multicentre, Phase 3 study to evaluate the efficacy and safety of Ticagrelor and acetylsalicylic acid (ASA) in preventing stroke and death in patients with acute ischaemic stroke or transient ischaemic attack THALES- Acute stroke or transient ischaemic attack in patients treated with Ticagrelor and acetylsalicylic acid (ASA) to prevent stroke and death. Poltava State Medical University. № 0125U002133
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку